By integrating the expression levels of these genes across various pathological stages and conducting correlation analyses with tumor stemness, we discovered that MRPL17 serves as an important stem cell marker gene pertinent to the prognosis and progression of LIHC. The gene discussed is MRPL17; the disease is neoplasm.